Food for thought: the importance of glucose and other energy substrates for sustaining brain function under varying levels of activity.

The brain requires a constant and substantial energy supply to maintain its main functions. For decades, it was assumed that glucose was the major if not the only significant source of energy for neurons. This view was supported by the expression of specific facilitative glucose transporters on cerebral blood vessels, as well as neurons. Despite the fact that glucose remains a key energetic substrate for the brain, growing evidence suggests a different scenario. Thus astrocytes, a major type of glial cells that express their own glucose transporter, play a critical role in coupling synaptic activity with glucose utilization. It was shown that glutamatergic activity triggers an enhancement of aerobic glycolysis in this cell type. As a result, lactate is provided to neurons as an additional energy substrate. Indeed, lactate has proven to be a preferential energy substrate for neurons under various conditions. A family of proton-linked carriers known as monocarboxylate transporters has been described and specific members have been found to be expressed by endothelial cells, astrocytes and neurons. Moreover, these transporters are subject to fine regulation of their expression levels and localization, notably in neurons, which suggests that lactate supply could be adjusted as a function of their level of activity. Considering the importance of energetics in the aetiology of several neurodegenerative diseases, a better understanding of its cellular and molecular underpinnings might have important implications for the future development of neuroprotective strategies.

Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperones.

α-Synuclein aggregation and accumulation in Lewy bodies are implicated in progressive loss of dopaminergic neurons in Parkinson disease and related disorders. In neurons, the Hsp70s and their Hsp40-like J-domain co-chaperones are the only known components of chaperone network that can use ATP to convert cytotoxic protein aggregates into harmless natively refolded polypeptides. Here we developed a protocol for preparing a homogeneous population of highly stable β-sheet enriched toroid-shaped α-Syn oligomers with a diameter typical of toxic pore-forming oligomers. These oligomers were partially resistant to in vitro unfolding by the bacterial Hsp70 chaperone system (DnaK, DnaJ, GrpE). Moreover, both bacterial and human Hsp70/Hsp40 unfolding/refolding activities of model chaperone substrates were strongly inhibited by the oligomers but, remarkably, not by unstructured α-Syn monomers even in large excess. The oligomers acted as a specific competitive inhibitor of the J-domain co-chaperones, indicating that J-domain co-chaperones may preferably bind to exposed bulky misfolded structures in misfolded proteins and, thus, complement Hsp70s that bind to extended segments. Together, our findings suggest that inhibition of the Hsp70/Hsp40 chaperone system by α-Syn oligomers may contribute to the disruption of protein homeostasis in dopaminergic neurons, leading to apoptosis and tissue loss in Parkinson disease and related neurodegenerative diseases.

Reinforced Earth and Stone Columns for Weak Subsoil Conditions, HR-510, 1980

Reinforced Earth is a French development that has been used in the United States for approximately ten years. Virbro-Replacement, more commonly referred to as stone columns, is an outgrowth of deep densification of cohesionless soils originally developed in Germany. Reinforced Earth has applicability when wall height is greater than about twelve feet and deep seated foundation failure is not a concern. Stone columns are applicable when soft, cohesive subsoil conditions are encountered and bearing capacity and shearing resistance must be increased. The conditions in Sioux City on Wesley Way can be summarized as: (1) restricted right of way, (2) fill height in excess of 25 feet creating unstable conditions, (3) adjacent structures that could not be removed. After analyzing alternatives, it was decided that Reinforced Earth walls constructed on top of stone columns were the most practical approach.

Laser-Ultraviolet-A induced ultra weak photon emission in human skin cells: A biophotonic comparison between keratinocytes and fibroblasts

Photons participate in many atomic and molecular interactions and processes. Recent biophysical research has discovered an ultraweak radiation in biological tissues. It is now recognized that plants, animal and human cells emit this very weak biophotonic emission which can be readily measured with a sensitive photomultiplier system. UVA laser induced biophotonic emission of cultured cells was used in this report with the intention to detect biophysical changes between young and adult fibroblasts as well as between fibroblasts and keratinocytes. With suspension densities ranging from 1-8x106 cells/ml, it was evident that an increase of the UVA-laser-light induced photon emission intensity could be observed in young as well as adult fibroblastic cells. By the use of this method to determine ultraweak light emission, photons in cell suspensions in low volumes (100 mu l) could be detected, in contrast to previous procedures using quantities up to 10 ml. Moreover, the analysis has been further refined by turning off the photomultiplier system electronically during irradiation leading to the first measurements of induced light emission in the cells after less than 10 mu s instead of more than 100 milliseconds. These significant changes lead to an improvement factor up to 106 in comparison to classical detection procedures. In addition, different skin cells as fibroblasts and keratinocytes stemining from the same donor were measured using this new highly sensitive method in order to find new biophysical insight of light pathways. This is important in view to develop new strategies in biophotonics especially for use in alternative therapies.

Capturing Weak Signals for Foresight Building

Tulevaisuuden hahmottamisen merkitys heikkojen signaalien avulla on korostunut viime vuosien aikana merkittävästi,koska yrityksen liiketoimintaympäristössä tapahtuvia muutoksia on ollut yhä vaikeampaa ennustaa historian perusteella. Liiketoimintaympäristössä monien muutoksien merkkejä on ollut nähtävissä, mutta niitä on ollut vaikea havaita. Heikkoja signaaleja tunnistamalla ja keräämällä sekä reagoimalla tilanteeseen riittävän ajoissa, on mahdollista saavuttaa ylivoimaista kilpailuetua. Kirjallisuustutkimus keskittyy heikkojen signaalien tunnistamisen haasteisiin liiketoimintaympäristöstä, signaalien ja informaation kehittymiseen sekä informaation hallintaan organisaatiossa. Kiinnostus näihin perustuu tarpeeseen määritellä heikkojen signaalien tunnistamiseen vaadittava prosessi, jonka avulla heikot signaalit voidaan huomioida M-real Oyj:n päätöksenteossa. Kirjallisuustutkimus osoittaa selvästi sen, että heikkoja signaaleita on olemassa ja niitä pystytään tunnistamaan liiketoimintaympäristöstä. Signaaleja voidaan rikastuttaa yrityksessä olevalla tietämyksellä ja hyödyntää edelleen päätöksenteossa. Vertailtaessa sekä kirjallisuustutkimusta että empiiristä tutkimusta tuli ilmi selkeästi tiedon moninaisuus; määrä,laatu ja tiedonsaannin oikea-aikaisuus päätöksenteossa. Tutkimuksen aikana kehittyi prosessimalli tiedon suodattamiselle, luokittelulle ja heikkojen signaalien tunnistamiselle. Työn edetessä prosessimalli kehittyi osaksi tässä työssä kehitettyä kokonaisuutta 'Weak Signal Capturing' -työkalua. Monistamalla työkalua voidaan kerätä heikkoja signaaleja eri M-realin liiketoiminnan osa-alueilta. Tietoja systemaattisesti kokoamalla voidaan kartoittaa tulevaisuutta koko M-realille.